Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Federal Circuit Reverses District of Delaware on Prosecution Laches and
Inequitable Conduct
On Nov. 9, 2010, the Federal Circuit delivered its opinion in Cancer Research Labs. v. Barr Labs., Civ. No. 10-1204. The case involved a single patent, 5,260,291, titled “Tetrazine derivatives” (the '291 patent). The patent claims a genus of tetrazine derivative compounds and methods for treating cancer by administering those compounds. One claimed compound, temozolomide, is the active ingredient in the drug Temodar', approved by the Food and Drug Administration (“FDA”) for the treatment of two types of brain cancer, refractory anaplastic astrocytoma and glioblastoma multiforme.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.
A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.